Nanoparticle curcumin ameliorates experimental colitis via modulation of gut microbiota and induction of regulatory T cells

Author:

Ohno Masashi,Nishida AtsushiORCID,Sugitani Yoshihiko,Nishino Kyohei,Inatomi Osamu,Sugimoto Mitsushige,Kawahara Masahiro,Andoh Akira

Funder

a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan

the Intractable Diseases from the Ministry of Health, Labor and Welfare of Japan

the Practical Research Project for Rare/Intractable Diseases from the Japan Agency for Medical Research and Development, AMED

the Smoking Research Foundation

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference38 articles.

1. Inflammatory bowel disease;DK Podolsky;The New England journal of medicine,2002

2. The microbiota in inflammatory bowel disease;D Sheehan;J Gastroenterol,2015

3. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases;M Sun;J Gastroenterol,2016

4. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials;A Shehzad;Arch Pharm (Weinheim),2010

5. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases;AB Kunnumakkara;British journal of pharmacology,2016

Cited by 151 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3